Riccio et al., 2011 - Google Patents

Excess of serotonin affects neocortical pyramidal neuron migration

Riccio et al., 2011

View HTML @Full View
Document ID
2027200447422760038
Author
Riccio O
Jacobshagen M
Golding B
Vutskits L
Jabaudon D
Hornung J
Dayer A
Publication year
Publication venue
Translational Psychiatry

External Links

Snippet

The serotonin transporter (SERT) is a key molecule involved in the homeostasis of extracellular levels of serotonin and is regulated developmentally. Genetic deletion of SERT in rodents increases extracellular levels of serotonin and affects cellular processes involved …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Riccio et al. Excess of serotonin affects neocortical pyramidal neuron migration
Sun et al. Potassium channel dysfunction in human neuronal models of Angelman syndrome
La Fata et al. FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry
Williams et al. AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress
Oguro-Ando et al. Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR
Kim et al. Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia
Wang et al. SynGAP regulates protein synthesis and homeostatic synaptic plasticity in developing cortical networks
Rivero et al. Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition
Maguschak et al. β-catenin is required for memory consolidation
Miller et al. Birdsong decreases protein levels of FoxP2, a molecule required for human speech
Han et al. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties
Sowers et al. Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction
Riccio et al. Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6
Jabaudon et al. ROR β induces barrel-like neuronal clusters in the developing neocortex
Hoshina et al. Protocadherin 17 regulates presynaptic assembly in topographic corticobasal Ganglia circuits
Faucherre et al. piezo2b regulates vertebrate light touch response
Fumagalli et al. Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress
Qin et al. Deficiency of autism risk factor ASH1L in prefrontal cortex induces epigenetic aberrations and seizures
Mellado-Gil et al. The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity
Carneiro et al. Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis
Rachdi et al. Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance
Becker et al. Presynaptic dysfunction in CASK-related neurodevelopmental disorders
Murillo et al. Temporal dynamics and neuronal specificity of Grin3a expression in the mouse forebrain
Hertel et al. Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse
Choi et al. Autism associated gene, engrailed2, and flanking gene levels are altered in post-mortem cerebellum